跳至主要内容
临床试验/NCT05998174
NCT05998174尚未招募早期 1 期

Faecal Microbiota Transplantation for Microscopic Colitis

Hvidovre University Hospital0 个研究点目标入组 20 人开始时间: 2023年9月最近更新:
适应症

试验速览

阶段
早期 1 期
状态
尚未招募
入组人数
20
主要终点
Treatment effect

研究概览

简要总结

A pilot study investigating if orally administrated faecal microbiota transplantation capsules have the potential to treat active microscopic colitis.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of microscopic colitis
  • Date of diagnosis/histological confirmation < 12 months
  • Active disease according to Hjortswang's criteria

排除标准

  • Diagnosed with ulcerative colitis or Crohn's disease
  • Diagnosed with celiac disease
  • Active gastrointestinal infection
  • Previous bowel resection of bowel (except appendectomy)
  • Previous cholecystectomy
  • Treatment with systemic steroid within 4 weeks, including budesonide
  • Antibiotics 3 months prior
  • Severe immunodeficiency,
  • Pregnancy, planned pregnancy and breastfeeding
  • Treatment with constipants such as psyllium, loperamide, bile binders, opium drops or codeine up to 2 weeks before inclusion and during participation

结局指标

主要结局

Treatment effect

时间窗: 3 weeks

Proportion of participants in remission

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sigen Wildt

Consultant, MD, ph.d

Hvidovre University Hospital

相似试验